S2CID 210954338.
Key Findings From Clinical Trials The FDA approval was based on strong results from the OASIS clinical trial programme and the large SELECT cardiovascular outcomes trial
The second is compounded semaglutide in sublingual tablet form, taken daily by dissolving under the tongue
Ready for deeper support
Serious Side Effects Less common but more serious side effects can include acute pancreatitis (severe abdominal pain that does not resolve), acute gallbladder disease (upper stomach pain, jaundice, fever), acute kidney injury (often related to dehydration from GI side effects), serious allergic reactions, hypoglycemia (especially if taking other diabetes medications), and mental health changes including suicidal thoughts
Correcting identified deficiencies If blood work reveals specific deficiencies (low ferritin, low vitamin D, low zinc, or low B12), targeted correction may be the single most effective intervention